04-Nov-2010 - ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.
02-Nov-2010 - Baxter International will sell its US generic injectables business to UK-based manufacturer Hikma Pharmaceuticals
25-Oct-2010 - US Biotechnology firm Genzyme predicts 2011 earnings in $4.30 to $4.60 range, which would make it worth $89 per share or $22.7bn.
20-Oct-2010 - Sanofi Aventis has been given the go ahead to pursue US biotech Genzyme by the country’s antitrust authorities.
19-Oct-2010 - Industrial catalysis firm WR Grace has been OKed to acquire fine chemicals group Synthetech by the US Bankruptcy Court.
11-Oct-2010 - Sanofi Aventis says eliminating 1,700 jobs in US will help it concentrate resources on business development, investment in late-stage development projects and will position it for growth after patent expiry.
04-Oct-2010 - French drugmaker Sanofi Aventis has tabled an $18.5m, $69 per share, hostile takeover bid for Genzyme after failing to secure an amicable acquisition.
30-Sep-2010 - Lupin has notified the Bombay Stock Exchange (BSE) that is has acquired a majority stake in Australian pharmaceutical company, Generic Health.
23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
22-Sep-2010 - Abbott Laboratories says it will shed manufacturing jobs as part integration of the pharmaceutical business it bought from Solvay earlier this year.
08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.
31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”
30-Aug-2010 - Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.
30-Aug-2010 - Proposed changes to compulsory licensing and foreign ownership oversight in India sparked discussion last week. To explore the topic, in-PharmaTechnologist presents interactive charts detailing market changes in the country over...
30-Aug-2010 - Sanofi Aventis has gone public with its $18.5bn (€14.5bn) takeover bid for US biotech Genzyme, putting more pressure on firm’s “unwilling” board
26-Aug-2010 - The Flexibles packaging unit acquired in Alcan Packaging deal boost sales, but integration costs hit fiscal 2010 net profit at Australia’s Amcor.
25-Aug-2010 - India is considering strengthening compulsory licensing provisions, which allow third parties to produce patented products, in response to concerns about overseas takeovers and drug prices.
25-Aug-2010 - Indian pharmaceutical firm Cipla is to buy Meditab Specialties to boost active pharmaceutical ingredient (API) and intermediate production capacity.
18-Aug-2010 - Imclone has closed the manufacturing facility in Branchburg, New Jersey where it produces the cancer drug Erbitux, according to reports in the US media.
11-Aug-2010 - US drugmaker Merck & Co has announced plans to reacquire a Pennsylvania manufacturing plant to guarantee supply of key active pharmaceutical ingredient (API).
10-Aug-2010 - Endo Pharmaceuticals will pay $168m (€127.7m) for drug delivery tech and formulations firm Penwest Pharmaceuticals in bid to expand pain portfolio.
03-Aug-2010 - Calls for US government to break Genzyme’s Fabrazyme patents accompany more speculation that French drugmaker Sanofi Aventis is in takeover talks.
03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.
02-Aug-2010 - Heinkel expands pharmaceutical filtering and drying systems business with acquisition of Italian equipment maker Comber.
29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...